Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-((1h-pyrazolo(3,4-b)pyridin-5-yl)ethynyl)-4-methyl-n-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide
2. 4-methyl-n-(4-((4-methyl-1-piperazinyl)methyl)-3-(trifluoromethyl)phenyl)-3-(2-(1h-pyrazolo(3,4-b)pyridin-5-yl)ethynyl)benzamide
3. Benzamide, 4-methyl-n-(4-((4-methyl-1-piperazinyl)methyl)-3-(trifluoromethyl)phenyl)-3-(2-(1h-pyrazolo(3,4-b)pyridin-5-yl)ethynyl)-, Methanesulfonate (1:2)
4. D-824
5. D-824 Dimesylate
6. D824
7. Gzd-824
8. Gzd-824 Dimesylate
9. Gzd824
10. Hqp-1351
11. Hqp-1351 Dimesylate
12. Hqp1351
13. Hqp1351 Dimesylate
14. Olverembatinib
15. Olverembatinib Dimesylate
1. 1421783-64-3
2. Gzd824
3. Gzd-824 Dimesylate
4. D-824 Dimesylate
5. Npj9aw8azr
6. Olverembatinib (dimesylate)
7. Methanesulfonic Acid;4-methyl-n-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-(1h-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]benzamide
8. Olverembatinib Dimesylate
9. Hqp1351 Dimesylate
10. Hqp-1351 Dimesylate
11. Benzamide, 4-methyl-n-(4-((4-methyl-1-piperazinyl)methyl)-3-(trifluoromethyl)phenyl)-3-(2-(1h-pyrazolo(3,4-b)pyridin-5-yl)ethynyl)-, Methanesulfonate (1:2)
12. Unii-npj9aw8azr
13. Schembl14953403
14. Hms3653c17
15. Bcp11025
16. Ex-a1365
17. Hy-15666a
18. Akos026750482
19. Ccg-270412
20. Ac-35746
21. Db-085418
22. Cs-0020021
23. S7194
24. Sw219345-1
25. 3-((1h-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)-4-methyl-n-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide Dimethanesulfonate
| Molecular Weight | 724.8 g/mol |
|---|---|
| Molecular Formula | C31H35F3N6O7S2 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 6 |
| Exact Mass | 724.19607431 g/mol |
| Monoisotopic Mass | 724.19607431 g/mol |
| Topological Polar Surface Area | 203 Ų |
| Heavy Atom Count | 49 |
| Formal Charge | 0 |
| Complexity | 1000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
ABOUT THIS PAGE
A HQP1351 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of HQP1351, including repackagers and relabelers. The FDA regulates HQP1351 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. HQP1351 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A HQP1351 supplier is an individual or a company that provides HQP1351 active pharmaceutical ingredient (API) or HQP1351 finished formulations upon request. The HQP1351 suppliers may include HQP1351 API manufacturers, exporters, distributors and traders.
HQP1351 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of HQP1351 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right HQP1351 GMP manufacturer or HQP1351 GMP API supplier for your needs.
A HQP1351 CoA (Certificate of Analysis) is a formal document that attests to HQP1351's compliance with HQP1351 specifications and serves as a tool for batch-level quality control.
HQP1351 CoA mostly includes findings from lab analyses of a specific batch. For each HQP1351 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
HQP1351 may be tested according to a variety of international standards, such as European Pharmacopoeia (HQP1351 EP), HQP1351 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (HQP1351 USP).
LOOKING FOR A SUPPLIER?
